Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes

Published:2011-12-12 Issue:12 Volume:6 Page:e29008
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Axelsson Stina,Chéramy Mikael,Hjorth Maria,Pihl Mikael,Åkerman Linda,Martinuzzi Emanuela,Mallone Roberto,Ludvigsson Johnny,Casas Rosaura

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. The pathogenesis of insulin-dependent diabetes mellitus.;MA Atkinson;N Engl J Med,1994

2. T cells in the pathogenesis of type 1 diabetes.;R Mallone;Curr Diab Rep,2008

3. Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity.;J Ludvigsson;Diabetologia,2009

4. Identificaion of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.;S Baekkeskov;Nature,1990

5. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.;D Kaufman;Nature,1993

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring immunomodulation strategies in type 1 diabetes;Frontiers in Immunology;2023-06-06

2. Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype;Frontiers in Immunology;2023-02-02

3. Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies;Journal of Immunology Research;2022-05-25

4. Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial;Future Science OA;2020-08-01

5. GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells;Diabetologia;2020-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3